Sonic Healthcare Ltd
SHL: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| JK& | LOCK|$$%^% | LOCK|%<?F>mq |
Sonic Healthcare: Strong Start to the Year; Shares Undervalued
Sonic Healthcare reaffirmed fiscal 2026 EBITDA guidance of 8% growth at the midpoint in constant currency terms, with solid organic sales growth of 5% year to date. Management also guides to modestly lower fiscal 2026 depreciation and interest expense. Shares reacted positively, up 6%.
